Podcast

Your Cancer Game Plan

Author(s):

Katie Kosko,Brielle Benyon

Mike Schmidt developed stage 3 melanoma after years of playing professional baseball for the Philadelphia Phillies.

For this week's episode of CURE Talks Cancer, we spoke with MLB Hall of Famer and former Phillies player, Mike Schmidt.

Schmidt was diagnosed with stage 3 melanoma, which eventually metastasized, but he held his head high throughout his cancer journey. Listen in to see how he stayed positive, as well as what he's now doing to promote sun safety for sports fans in Philadelphia.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with text.
Image of patient and doctor.
Image of Dr. Doug
Immune Therapy Expands Melanoma Treatment to More Patients
Image of a man with dark hair and some facial hair.
Image of a man with blond facial hair.
Image of a woman with blond hai
Dr. Manisha Thakuria in an interview with CURE
Dr. Beth Goldstein in an interview with CURE
Related Content
Adding SCIB1 or iSCIB1+ to standard treatments helped more patients with advanced melanoma respond and live longer without extra side effects: © stock.adobe.com.
July 31st 2025

New Treatment Combo Improves Advanced Melanoma Outcomes

Spencer Feldman
Adding SCIB1 or iSCIB1+ to standard treatments helped more patients with advanced melanoma respond and live longer without extra side effects.
cancer horizons logo: a white microphone on a navy blue background
July 31st 2025

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of man with text..
July 31st 2025

Key Skin Cancer Treatment Updates From 2025 and What is Still to Come

Ryan Scott
Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for patients with high-risk skin cancer.
cancer horizons podcast logo: a white microphone on a blue background
July 31st 2025

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
A A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma: © stock.adobe.com.
July 31st 2025

Real-World Data Supports Amtagvi’s Benefit in Advanced Melanoma

Spencer Feldman
A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.
TIL therapy is on the rise in melanoma, with potential for other tumor types.
July 31st 2025

Empowering the Immune System

Darlene Dobkowski, MA
TIL therapy is on the rise in melanoma, with potential for other tumor types.